Original: $225.00
-65%$225.00
$78.75The Story
Boston Scientific M00576570 Ultraflex Tracheobronchial Distal Release Stent System 14mm x 30mm Covered 15mm 1/EA
• Model: M00576570
• Expanded Stent Outer Diameter: 14 mm
• Expanded Stent Length: 30 mm
• Cover Length: 15 mm
• Compressed Delivery Profile: ~9 Fr.
• Guidewire Compatibility: Compatible with standard 0.035″ Jagwire or pulmonary guidewires
The Boston Scientific M00576570 Ultraflex™ Tracheobronchial Distal Release Stent System delivers reliable airway support for patients facing tracheobronchial strictures caused by malignant or obstructive disease. Engineered with a 14 mm expanded diameter and 30 mm length, this partially covered airway stent combines a silicone-covered midsection to resist tumor ingrowth with uncovered nitinol ends that promote mucociliary clearance and help limit migration. The knitted, self-expanding nitinol design provides constant radial force to maintain airway patency while adapting to anatomical contours, offering a balance of strength and flexibility.
Designed for precision deployment, the Ultraflex stent is delivered through a distal-release catheter outfitted with radiopaque markers for enhanced fluoroscopic visibility and accurate positioning during bronchoscopy procedures. Its low-profile delivery system facilitates smooth navigation through complex airway anatomies using either flexible or rigid bronchoscopic techniques, and the approximately 95 cm working length supports procedural versatility across a wide range of clinical scenarios.
Indicated for use by trained physicians in interventional pulmonology and thoracic surgery, the Ultraflex™ Tracheobronchial Stent System (M00576570) presents a durable, single-use solution for relieving airway obstruction and improving patient breathing comfort. Whether used for malignant strictures or other airway compromise, its combination of tumor-resistant coverage, adaptive nitinol architecture, and precise deployment capability makes it a trusted choice for maintaining airway integrity and enhancing clinical outcomes.
Details & Craftsmanship
Every detail has been carefully considered to bring you the perfect product.
Details & Craftsmanship
Every detail has been carefully considered to bring you the perfect product.
Description
Boston Scientific M00576570 Ultraflex Tracheobronchial Distal Release Stent System 14mm x 30mm Covered 15mm 1/EA
• Model: M00576570
• Expanded Stent Outer Diameter: 14 mm
• Expanded Stent Length: 30 mm
• Cover Length: 15 mm
• Compressed Delivery Profile: ~9 Fr.
• Guidewire Compatibility: Compatible with standard 0.035″ Jagwire or pulmonary guidewires
The Boston Scientific M00576570 Ultraflex™ Tracheobronchial Distal Release Stent System delivers reliable airway support for patients facing tracheobronchial strictures caused by malignant or obstructive disease. Engineered with a 14 mm expanded diameter and 30 mm length, this partially covered airway stent combines a silicone-covered midsection to resist tumor ingrowth with uncovered nitinol ends that promote mucociliary clearance and help limit migration. The knitted, self-expanding nitinol design provides constant radial force to maintain airway patency while adapting to anatomical contours, offering a balance of strength and flexibility.
Designed for precision deployment, the Ultraflex stent is delivered through a distal-release catheter outfitted with radiopaque markers for enhanced fluoroscopic visibility and accurate positioning during bronchoscopy procedures. Its low-profile delivery system facilitates smooth navigation through complex airway anatomies using either flexible or rigid bronchoscopic techniques, and the approximately 95 cm working length supports procedural versatility across a wide range of clinical scenarios.
Indicated for use by trained physicians in interventional pulmonology and thoracic surgery, the Ultraflex™ Tracheobronchial Stent System (M00576570) presents a durable, single-use solution for relieving airway obstruction and improving patient breathing comfort. Whether used for malignant strictures or other airway compromise, its combination of tumor-resistant coverage, adaptive nitinol architecture, and precise deployment capability makes it a trusted choice for maintaining airway integrity and enhancing clinical outcomes.
